Assignee
CELLTRION INC
KR30 patents
Top patents by PatentIndex Score
US10980881B2Apr 20, 2021
Stable liquid formula having an anti-TNFalpha antibody, acetate buffer and glycine
CELLTRION INC7 citations81
US9834594B2Dec 5, 2017
Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza A viruses
CELLTRION INC2 citations71
US9856312B2Jan 2, 2018
Binding molecule having influenza A virus-neutralizing activity produced from human B cell
CELLTRION INC3 citations68
US9814784B2Nov 14, 2017
Antibody-linker-drug conjugate, preparation method therefor, and anticancer drug composition containing same
CELLTRION INC2 citations68
US11986523B2May 21, 2024
Stable liquid formula comprising anti-TNFa antibody, acetate buffer, and glycine
CELLTRION INC1 citations59
US11236146B2Feb 1, 2022
Stable pharmaceutical formulation
CELLTRION INC0 citations59
US11202751B2Dec 21, 2021
Whitening cosmetic composition comprising Caragana sinica root extract
CELLTRION INC0 citations59
US10703802B2Jul 7, 2020
Composition comprising at least two influenza A virus-neutralizing-binding molecules
CELLTRION INC1 citations59
US11007136B2May 18, 2021
Cosmetic composition for wrinkle reduction containing gypenoside isolated from Gynostemma pentaphyllum
CELLTRION INC0 citations58
US9475861B2Oct 25, 2016
Binding molecule having influenza A virus-neutralizing activity produced from human B cell
CELLTRION INC2 citations58
US9278996B2Mar 8, 2016
Dolastatin-10 derivative, method of producing the same and anticancer drug composition containing the same
CELLTRION INC2 citations58
US12534738B2Jan 27, 2026
Expression cassette including intron for high expression of protein of interest and use thereof
CELLTRION INC0 citations57
US12188036B2Jan 7, 2025
Expression cassette for production of high-expression and high-functionality target protein and use thereof
CELLTRION INC1 citations57
US11951207B2Apr 9, 2024
Stable liquid pharmaceutical preparation
CELLTRION INC0 citations57
US11730698B2Aug 22, 2023
Stable liquid pharmaceutical preparation
CELLTRION INC0 citations57
US10947497B2Mar 16, 2021
Nelumbo nucifera callus extract having increased content of gallic acid, method for preparing same, and whitening cosmetic composition containing same
CELLTRION INC0 citations56
US12419863B2Sep 23, 2025
Pharmaceutical composition for use in treatment of hypertrophic cardiomyopathy
CELLTRION INC0 citations55
US10722571B2Jul 28, 2020
Rabies virus G protein epitope, and rabies virus neutralising binding molecule that binds specifically thereto
CELLTRION INC1 citations55
US12533343B2Jan 27, 2026
Method for preparing (−)-cibenzoline succinate
CELLTRION INC0 citations54
US12551465B2Feb 17, 2026
Pharmaceutical composition for treatment of hypertrophic cardiomyopathy and treatment method using same composition
CELLTRION INC0 citations51
US12065482B2Aug 20, 2024
Stable liquid pharmaceutical formulation of anti-influenza virus antibody
CELLTRION INC0 citations49
US12546779B2Feb 10, 2026
Binding molecule having neutralizing activity against SARS-coronavirus-2
CELLTRION INC0 citations46
US10507240B2Dec 17, 2019
Epitope of hepatitis B virus surface antigen and binding molecule specifically binding to same for neutralizing hepatitis B virus
CELLTRION INC0 citations46
US10610587B2Apr 7, 2020
Adjuvant composition containing at least one influenza virus neutralizing and binding molecule and vaccine composition containing same
CELLTRION INC0 citations44
US12157764B2Dec 3, 2024
Dosing regimen for treating influenza virus diseases
CELLTRION INC0 citations43
US10239902B2Mar 26, 2019
Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition comprising same
CELLTRION INC0 citations43
US12486237B2Dec 2, 2025
Polymorphic form of (-)-cibenzoline succinate
CELLTRION INC0 citations42
US8361790B2Jan 29, 2013
Human host cell for producing recombinant proteins with high quality and quantity
CELLTRION INC0 citations39
US11712407B2Aug 1, 2023
Hybrid-type multi-lamellar nanostructure of epidermal growth factor and liposome and method for manufacturing same
CELLTRION INC0 citations38
US10351592B2Jul 16, 2019
Method for separating antibody isoforms using cation exchange chromatography
CELLTRION INC0 citations30